# Hims & Hers Health Narrows 2026 Guidance After Q3 Results By John Kim Canonical URL: https://www.tokenpost.com/news/business/53415 Published: 2026-11-10T23:59:12.000Z Updated: 2026-11-10T23:59:12.000Z Section: Business > The telehealth provider projects full-year 2026 revenue of $3.13 billion to $3.15 billion and narrowed its EBITDA guidance. Hims & Hers Health reported third-quarter results that missed expectations Monday, Nov. 9, and narrowed its 2026 guidance, setting a full-year revenue forecast of $3.13 billion to $3.15 billion. The telehealth provider also narrowed its EBITDA guidance for 2026. Its shares were at [$22.12, down 14.92%, at 9:41 a.m. ET (14:41 UTC) Tuesday, Nov. 10](). ## Links in this article - [$22.12, down 14.92%, at 9:41 a.m. ET (14:41 UTC) Tuesday, Nov. 10](https://www.tokenpost.com/news/investing/53163)